ARA-290, manufactured by Peptides Sciences, is a synthetic peptide engineered to mimic the tissue-protective effects of erythropoietin (EPO) without stimulating red blood cell production. This innovative peptide is designed to support neuropathic pain relief, tissue repair, and anti-inflammatory benefits.
Benefits of ARA-290:
- Neuropathic Pain Reduction – Helps alleviate chronic pain by modulating inflammatory responses.
- Tissue Regeneration – Promotes healing in damaged tissues, making it beneficial for injuries.
- Anti-Inflammatory Properties – Reduces inflammation, supporting overall immune health.
- Endothelial Repair – Enhances blood vessel function, aiding cardiovascular health.
Recommended Cycle:
- Dosage: Commonly administered at 0.1-0.5 mg per injection, typically subcutaneously.
- Frequency: 3–5 times per week, depending on individual needs and research protocols.
- Duration: 4–8 weeks for optimal results, followed by a break to assess effects.
Potential Side Effects:
- Mild Injection Site Reactions – Temporary redness, swelling, or irritation.
- Fatigue or Headache – Occasionally reported in sensitive individuals.
- Rare Hypotension – Lowered blood pressure in some users.
Peptides Sciences ensures high-quality, research-grade ARA-290 for scientific and investigational use. Always consult a medical professional before use.
